πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

LIGAND PHARMACEUTICALS Patents

Full USPTO pharma patent portfolio for LIGAND PHARMACEUTICALS β€” grant dates, expiration, and drug cross-links.

Patents
133
Expiring ≀24m
12

Quick answer

LIGAND PHARMACEUTICALS has 133 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 12 expire within 24 months β€” use filters for patent-cliff planning.

Page 2 of 3

  1. US 7919248

    Methods for the modulation of IL-13

    Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7816372

    6-cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds

    Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7727980

    Tricyclic androgen receptor modulator compounds and methods

    Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7696246

    Bicyclic androgen and progesterone receptor modulator compounds and methods

    Expires Mon Apr 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7691895

    Thrombopoietin activity modulating compounds and methods

    Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7442696

    Mineralocorticoid receptor modulator compounds, processes for their preparation, and their uses

    Expires Mon Oct 23 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7439027

    Method for modulating process mediated by farnesoid activated receptors

    Expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7435733

    Mineralocorticoid receptor modulator compounds and methods, and pharmaceutical compositions containing these compounds

    Expires Mon Oct 09 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7348359

    Retinoid X receptor modulators

    Expires Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7314887

    Thrombopoietin activity modulating compounds and methods

    Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7288258

    Polyepitopic protein fragments of the E6 and E7 proteins of HPV, their production and their use particularly in vaccination

    Expires Mon Oct 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7241783

    Thrombopoietin mimetics

    Expires Mon Jul 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7214690

    Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods

    Expires Mon May 03 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7192982

    Modulators of peroxisome proliferator activated receptors

    Expires Mon Mar 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7163946

    5-substituted 7,9-difluoro-5H-chromeno[3,4-f]quinoline compounds as selective progesterone receptor modulator compounds

    Expires Mon Jan 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7115728

    Human peroxisome proliferator activated receptor Ξ³

    Expires Mon Sep 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7098025

    Human peroxisome proliferator activated receptor gamma (pparΞ³) gene regulatory sequences and uses therefor

    Expires Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7084151

    5-(1',1'-cycloalkyl/alkenyl)methylidene 1,2-dihydro-5H-chromeno[3,4-Ζ’]quinolines as selective progesterone receptor modulator compounds

    Expires Mon Jul 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7081457

    Cyclothiocarbamate derivatives as progesterone receptor modulators

    Expires Mon Jul 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7071205

    5-cycloalkenyl 5H-chromeno[3,4-f]quinoline derivatives as selective progesterone receptor modulator compounds

    Expires Mon Jun 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7056954

    Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor

    Expires Mon Jun 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7026484

    Tricyclic androgen receptor modulator compounds and methods

    Expires Mon Apr 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  23. US 6992108

    Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor

    Expires Mon Jan 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  24. US 6982261

    Cyanopyrroles

    Expires Mon Dec 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  25. US 6964973

    Bicyclic androgen and progesterone receptor modulator compounds and methods

    Expires Mon Nov 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  26. US 6951942

    Glucocorticoid-selective anti-inflammatory agents

    Expires Mon Sep 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  27. US 6946454

    Thio-oxindole derivatives

    Expires Mon Sep 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  28. US 6841568

    Thio-oxindole derivatives

    Expires Mon Jan 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  29. US 6835744

    3,3-substituted indoline derivatives

    Expires Mon Dec 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  30. US 6825222

    Modulators of peroxisome proliferator activated receptors

    Expires Mon Nov 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  31. US 6794373

    Contraceptive methods using benzimidazolones

    Expires Mon Sep 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  32. US 6783763

    Polyepitopic proteinic fragments of the E6 and E7 HPV proteins, production and use thereof in vaccines

    Expires Mon Aug 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  33. US 6759408

    Combination regimens using progesterone receptor modulators

    Expires Mon Jul 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  34. US 6713478

    Cyclocarbamate derivatives as progesterone receptor modulators

    Expires Mon Mar 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  35. US 6696459

    Steroid receptor modulator compounds and methods

    Expires Mon Feb 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  36. US 6693103

    1,2,3,4-tetrahydro-2-thioxo-quinolinyl and 1,2,3,4-tetrahydro-2-oxo-quinolinyl derivatives as progesterone receptor modulators

    Expires Mon Feb 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  37. US 6670387

    Thrombopoietin mimetics

    Expires Mon Dec 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  38. US 6667313

    8-substituted-6-triflouromethyl-9-pyrido [3,2-G] quinoline compounds as androgen receptor modulators

    Expires Mon Dec 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  39. US 6610696

    Modulators of peroxisome proliferator activated receptors

    Expires Mon Aug 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  40. US 6608068

    Indoline derivatives

    Expires Mon Aug 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  41. US 6593493

    RXR modulators with improved pharmacologic profile

    Expires Mon Jul 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  42. US 6583145

    Thio-oxindole derivatives

    Expires Mon Jun 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  43. US 6576676

    Means for the modulation of processes mediated by retinold receptors and compounds useful therefor

    Expires Mon Jun 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  44. US 6566372

    Bicyclic androgen and progesterone receptor modulator compounds and methods

    Expires Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  45. US 6566358

    Cyclocarbamate derivatives as progesterone receptor modulators

    Expires Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  46. US 6544970

    Cyclic regimens utilizing indoline derivatives

    Expires Mon Apr 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  47. US 6545049

    Dimer-selective RXR modulators and methods for their use

    Expires Mon Apr 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  48. US 6521633

    Treating NIDDM with RXR agonists

    Expires Mon Feb 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does LIGAND PHARMACEUTICALS have?

133 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do LIGAND PHARMACEUTICALS patents expire?

12 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.